Category:
Prophylactic Biological Products
CAS NO:
184475-35-2
Standard:
In-house Standards,
Gefitinib is a drug used for certain breast, lung and other cancers.
It is in R&D stage.
Gefitinib is a small-molecule tyrosine kinase inhibitor used in oncology. The core synthesis involves heterocyclic condensation reactions. Key parameters include molecular formula C22H24ClFN4O3 and CAS number 184475-35-2.
Contraindicated in patients with EGFR-negative tumors. Storage requires controlled temperature between 20°C to 25°C in moisture-proof environments. Personnel must wear PPE during handling to prevent inhalation or skin contact exposure.